FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

1019311000001105: Tacalcitol 4micrograms/g ointment 30 gram (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
22467501000001118 Tacalcitol 4micrograms/g ointment 30 gram (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
22467601000001119 Tacalcitol 4micrograms/g ointment 30 gram en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

2 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tacalcitol 4micrograms/g ointment 30 gram Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Tacalcitol 4micrograms/g ointment 30 gram Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Tacalcitol 4micrograms/g ointment 30 gram Is pack of Product containing precisely tacalcitol (as tacalcitol monohydrate) 4 microgram/1 gram conventional release cutaneous ointment false Inferred relationship Existential restriction modifier
Tacalcitol 4micrograms/g ointment 30 gram Has active ingredient Tacalcitol false Inferred relationship Existential restriction modifier
Tacalcitol 4micrograms/g ointment 30 gram Has active ingredient Tacalcitol monohydrate false Inferred relationship Existential restriction modifier
Tacalcitol 4micrograms/g ointment 30 gram VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Tacalcitol 4micrograms/g ointment 30 gram VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Tacalcitol 4micrograms/g ointment 30 gram Has manufactured dose form Cutaneous AND/OR transdermal dosage form false Inferred relationship Existential restriction modifier
Tacalcitol 4micrograms/g ointment 30 gram Has VMP Product containing precisely tacalcitol (as tacalcitol monohydrate) 4 microgram/1 gram conventional release cutaneous ointment true Inferred relationship Existential restriction modifier
Tacalcitol 4micrograms/g ointment 30 gram Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Tacalcitol true Inferred relationship Existential restriction modifier
Tacalcitol 4micrograms/g ointment 30 gram Has specific active ingredient Tacalcitol monohydrate false Inferred relationship Existential restriction modifier
Tacalcitol 4micrograms/g ointment 30 gram Has dispensed dose form Ointment true Inferred relationship Existential restriction modifier
Tacalcitol 4micrograms/g ointment 30 gram Has specific active ingredient Tacalcitol monohydrate true Inferred relationship Existential restriction modifier
Tacalcitol 4micrograms/g ointment 30 gram Has basis of strength substance Tacalcitol true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Curatoderm 4micrograms/g ointment (Crookes Healthcare Ltd) 30 gram Is a True Tacalcitol 4micrograms/g ointment 30 gram Inferred relationship Existential restriction modifier
Curatoderm 4micrograms/g ointment (Mawdsley-Brooks & Company Ltd) 30 gram Is a True Tacalcitol 4micrograms/g ointment 30 gram Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start